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Psychometric properties of a new
treatment expectation scale in rheumatoid
arthritis: an application of item response
theory
Fowzia Ibrahim1,5*, Salma Ayis2, Darija Hofmann1, Diana Rose3, Til Wykes4, Andrew Cope1, David L. Scott1
and Heidi Lempp1
Abstract
Background: Patient-generated health outcome measures are important in the assessment of long-term treatment
goals for Rheumatoid Arthritis (RA), but few psychometrically sound measures are available. The MAPLe-RA (Measuring
Actual Patient-Led expectations in RA) is a new questionnaire and its psychometric properties are not investigated. This
study aims to examine these properties for each of the items using Item Response Theory (IRT) .
Methods: Participants were included if they completed the scale (MAPLe-RA). A one parameter (Rasch) model and a
two parameter logistic (2PL) model were applied to these data using M-plus software.
Results: One hundred thirty-eight patients with RA were included in the analysis. MAPLe-RA scale comprised of 21
items, the mean score was 71 (20.28) ranging from 0 to 105. Most items operated in the high expectations part of the
items characteristics curves (ICC). Item discrimination varied widely, items with the highest discrimination capacity from
the three domains were: pain (physical domain); control of my RA (self-management) and maintaining social
role (psycho-social domain); feeling better overall and involvement in treatment decision making (impact of
new treatment domain).
Conclusion: RA patients’ expectations of treatment are higher in the physical and psycho-social domains and less so
in the impact of new treatment domain.
Background
Patient- generated health outcome measures play an im-
portant role in the assessment of long-term treatment
goals, for people experiencing Rheumatoid arthritis (RA)
and are therefore well positioned to be utilised in asses-
sing new treatments. In RA, there is no gold standard
measure for the assessment of patient’s expectations at
time of diagnosis or before commencing treatment. To
fill this gap we developed a new patient-generated ex-
pectancy measure, called Measuring Actual Patient-Led
expectations in RA (MAPLe-RA) scale [1]. Item
response theory (IRT) is an approach that emphasizes
the influence of the individual’s qualities as well as the
items qualities, in a test, or in a questionnaire. The
method was originated in education where individual
qualities may reflect abilities, was then extended to other
applications, with well-known examples in medicine and
psychology [2–4]. In this study the underlying construct
is patients’ expectations, and the method was used to
understand the psychometric properties of the individual
items [5, 6]. Although IRT method has been applied in
several long-term conditions to assess the properties of
outcome measures and questionnaires [7], it is rarely
used in patient-generated measures in RA [8, 9]. For the
development of new scales, traditionally, a factor extraction
method based on Eigenvalues is used [10, 11] to explore
the number of domains, and the strength of association of
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Table 1 MAPLe-RA questionnaire
A. The Physical domain (physical impact of RA): with the new treatment, I expect:
Q1: The swelling of the joints to be Much
better
Better Same Worse Much
Worse
non-
applicable
Q2: The pain to be Much
better
Better Same Worse Much
Worse
non-
applicable
Q3: My morning stiffness to be Much
better
Better Same Worse Much
Worse
non-
applicable
Q4: My mobility to be Much
better
Better Same Worse Much
Worse
non-
applicable
Q5: My fatigue to be Much
better
Better Same Worse Much
Worse
non-
applicable
Q6: The visible signs of RA (e.g. deformities on my hands) to be Much
better
Better Same Worse Much
Worse
non-
applicable
Q7: The joint damage to be caused by RA Much
better
Better Same Worse Much
Worse
non-
applicable
Questions for physical domain are coded from 5 =Much better to 0 = non-applicable; overall score for the physical domain ranges between 0 and 35.
B. The Psycho-social domain (emotional wellbeing and social aspects of RA): with the new treatment, I expect:
Q1: To be able to maintain my independence (e.g. not needing to ask for
help making tea)
Much
more than
usual
More
than
usual
Same Worse
than
usual
Much
worse
than usual
non-
applicable
Q2: Improvements in my general health in order for me to be able to go
back to work and/ or stay in salaried employment: (Please tick here if not
applicable)
Much
more than
usual
More
than
usual
Same Worse
than
usual
Much
worse
than usual
non-
applicable
Q3: My everyday activities (e.g. shopping) to be facilitated: Much
more than
usual
More
than
usual
Same Worse
than
usual
Much
worse
than usual
non-
applicable
Q4: To feel in control of my RA self manage (e.g. diet)/ cope (e.g. frustration)
alongside medical treatment
Much
more than
usual
More
than
usual
Same Worse
than
usual
Much
worse
than usual
non-
applicable
Q5: To be able to maintain my social roles (e.g. supporting family/going out
with friends)
Much
more than
usual
More
than
usual
Same Worse
than
usual
Much
worse
than usual
non-
applicable
Q6: My emotional wellbeing (e.g. mood) to be Much
more than
usual
More
than
usual
Same Worse
than
usual
Much
worse
than usual
non-
applicable
Questions for the Psycho-social domain are coded from 5 =Much more than usual to 0 = non-applicable; overall score for the psycho-social domain
range between 0 and 30.
C. Impact of new Treatment (Overall Expectations on Impact of Treatment (care delivery)): with the new treatment I expect it:
Q1: To make me feel better overall despite side effects Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
Q2: To reduce the likelihood of surgery Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
Q3: To prevent other physical complications Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
Q4: To come with detailed information from the medical staff: Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
Q5: To allow me to be involved in the treatment decision making with the
clinical staff
Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
Q6: To include regular physical (e.g. hands and feet) assessments Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
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items within domains. IRT in addition provides import-
ant details, on psychometric properties of each item, in-
cluding, the difficulty and the discrimination of these
properties. MAPLe-RA is a new questionnaire and its
psychometric properties have not yet been investigated.
This study aims to examine these properties for each of
the items using IRT.
Methods
The development stages of MAPLe-RA were published
elsewhere [1]. In brief, stage one of the study: three re-
peated focus groups and two expert panels with RA
patients were conducted by a patient researcher. Stage
two: a feasibility study of the draft scale with 22 con-
secutive outpatient attendees over 1 week was conducted
and stage three was the psychometric analysis, and that
the results are presented here. MAPLe-RA scale, com-
prised of 21 items, and the response options were given
in a Likert scale from 5 to 0. High scores refer to better
treatment expectations. The scale is intended to measure
expectations of treatment in three domains: physical,
psychosocial and impact of treatment. Table 1 shows
how the MAPLe-RA questionnaire is scored. MAPLe-RA
was approved by the National Research Ethics Committee
London-Central (REC reference number 10/HO718/82).
All participants provided informed consent.
Data analysis
The demographic information of participants are de-
scribed in Table 2, using proportions, means and stand-
ard deviations (SD) as appropriate. The item responses
for all the 21 items were skewed towards ‘better’ and
‘much better’. For the factor analysis we used the ori-
ginal scales of the items. However, for the purpose of the
IRT model, we dichotomised the items by collapsing the
(i) ‘better’ and ‘much better’ responses together and
coded as 1; and (ii) ‘worst’, ‘much worst’, ‘same’ and ‘non-
applicable’ responses coded as 0. We fitted a one
parameter (Rasch) model which, assumes that the items
are equally discriminating but with varying difficulty,
and a two parameter logistic (2PL) model that assumes
the items have a varying ability to discriminate among pa-
tients with different levels of the underlying construct [13,
14]. Uni-dimensionality was assumed as a priori and was
further assessed using maximum likelihood method as
well as principal-component factor methods. We present
the results obtained from the 2PL model, as these provide
more desired information, including items’ difficulty and
discrimination [15, 16]. The model fits the data well as
assessed by the Akaike information criterion (AIC) and
Bayesian information criterion (BIC). We employed the
Item-characteristic Curve (ICC) to evaluate the profile of
each item within the scale and to assess the relationship
between the predicted patients’ response to an individual
item and the underlying construct (expectations). For all
the analyses we used M-Plus statistical software.
The two-parameter logistic model suits binary responses
and may be described as:
Table 1 MAPLe-RA questionnaire (Continued)
Q7: To include regular emotional wellbeing assessments Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
Q8: To allow me to not have to change medication so often Strongly
Agree
Agree Neither
Agree nor
Disagree
Disagree Strongly
Disagree
non-
applicable
Questions for the impact of new treatment are coded from 5 = strongly agree to 0 = non-applicable; overall score for the impact of new treatment
scores range between 0 and 40.
Computing and interpreting the MAPLe-RA score
There are two steps in computing the overall score of MAPLe-RA
1. Sum the scores for each domain
2. Sum the scores for all the domains. This yields a MAPLe-RA score ranging between 0 and 105. The highest score representing high expectations of new treat-
ment and vice versa
Non-applicable response category refers to patients who are not newly diagnosed with RA or not changing treatment
Table 2 Demographic information of participants in the study
n = 138
n (%)
Mean age (SD) 54 (14.30)
Gender
Female 101 (73 %)
Male 37 (27 %)
Ethnicity
White 73 (53 %)
Other 65 (47 %)
Disability
Yes 48 (35 %)
No/Unsure 90 (65 %)
SD standard deviation
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pðxj ¼ 1 θj Þ ¼ 1
1þ exp −aj θ−βj
 n o ð1Þ
Where xj is the observed response to item j, αj is the slope
parameter, βj is the difficulty (location) of item j, and θ is
the underlying construct being measured (expectations).
Results
Study participants
A total of 160 outpatient attendees were invited to take
part in phase 3 of the study, 138 (86 %) consented and
completed the MAPLe-RA questionnaire. The mean age
was 54 (SD = 14.30) years; 101 (74 %) were women, 73
(53 %) were of white ethnicity and 48 (38 %) reported
being registered disabled (Table 2).
MAPLe-RA scale properties
In stage one and two of the scale development, patients
identified 21 dimensions of new treatment expectations,
grouped into (i) physical (ii) psycho-social and (iii) ex-
pectations relating to impact of treatment. This resulted
in a draft questionnaire assessed in the feasibility study
and subsequent stage three analysis.
The overall mean score of MAPLe-RA 21 items, was 71
(SD: 20.28; range 0 to 105). The means for the 3 domains,
separately were: physical (7 items), mean 24.40 (SD: 7.21),
psycho-social (6 items), mean 17.51 (SD: 8.17) and impact
of new treatment domain (8 items) mean 30.76 (SD: 7.02).
Exploratory factor analysis identified that all items had
strong positive associations with the first factor, weak as-
sociations in most items with the second factor, and
negative associations with items 13–21 (Additional file 1:
Table S1). The Eigen value for the first factor was 6.25,
proportion of variance explained was 77 %, supporting the
uni-dimensionality of the items.
Most items had high rates of “yes” or positive re-
sponses, in IRT context, these have low difficulty pa-
rameters, most patients would pick, and these seem to
describe the majority of patients’ expectations. Item
Table 3 Item characteristics (difficulties and discrimination) for MAPLe-RA scale
Item discriminations Item difficulties
Items Estimate (SE) P-value Estimate (SE) P-value
Physical domain
Swelling of the joints 1.38 (0.58) 0.018 −1.22 (0.30) <0.001
Pain 1.74 (0.82) 0.034 −1.25 (0.30) <0.001
Morning stiffness 1.25 (0.47) 0.008 −1.00 (0.25) <0.001
Mobility 1.04 (0.41) 0.012 −1.16 (0.31) <0.001
Fatigue 0.87 (0.26) 0.001 −0.96 (0.25) <0.001
Visible signs of RA 0.49 (0.16) 0.002 0.19 (0.24) 0.427
Joint damage 0.40 (0.15) 0.006 −0.62 (0.34) 0.066
Psycho-social domain
Maintain my independence 1.46 (0.39) <0.001 −0.14 (0.13) 0.270
Improvements in my general health 0.85 (0.23) <0.001 0.06 (0.17) 0.712
Everyday activities 1.27 (0.40) 0.001 −0.32 (0.14) 0.027
To feel in control of my RA self-manage 1.64 (0.49) 0.001 −0.46 (0.13) 0.001
To maintain my social roles 1.87 (0.63) 0.003 −0.30 (0.12) 0.016
My emotional well-being 1.77 (0.51) 0.001 −0.42 (0.13) 0.001
Impact of new Treatment
Feel better overall 1.47 (0.38) <0.001 −1.02 (0.20) <0.001
Reduce the likelihood of surgery 0.89 (0.27) 0.001 −1.19 (0.29) <0.001
To prevent other physical complications 0.70 (0.27) 0.008 −1.47 (0.44) 0.001
To come with detailed information from themedical staff 1.16 (0.45) 0.010 −1.36 (0.34) <0.001
Decision making with the clinical staff 0.87 (0.34) 0.010 −1.65 (0.47) <0.001
Regular physical assessment 1.41 (0.52) 0.007 −1.36 (0.29) <0.001
Regular emotional well-being 0.81 (0.26) 0.001 −0.90 (0.25) <0.001
Not to have to change medication 0.52 (0.18) 0.005 −1.14 (0.40) 0.004
p-value is for the two parameter model
SE standard error
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discrimination on the other hand reflects the strength
of the association of an item with the underlying con-
struct, items with high discrimination are better at dif-
ferentiating respondents at the location point; small
changes in the underlying construct (expectation) leads
to large changes in the probability of endorsing the
item (response = yes), and vice versa for items with low
discrimination. These responses varied widely, and the
most powerful two items from the three domains were:
“swelling of the joints” and “pain” in the physical do-
mains, discriminations: 1.38 (0.58) and 1.74 (0.82).
In the psycho-social domains, “to maintain social
role” and “emotional wellbeing” were the two items
with highest discrimination: 1.87 (0.63) and 1.77 (0.51),
respectively. The two items with the highest discrimin-
ation in impact of new treatment domain were “feeling
better overall” and “involvement in treatment decision
making”, 1.47 (0.38) and 1.41 (0.52) respectively, and
other items had lower discrimination. Details for all
items are presented in (Table 3). Within the physical
domains, two items had a difficulty that was not
different from zero, namely “visible signs of RA” and
“joint damage”, and the two items also had very low
discrimination. The model fit was high in both the BIC
(2807.48) and AIC (2743.08), which indicates a good fit
of the two-parameter logistic model.
Figure 1 shows the Item Characteristic Curves (ICC)
that represents the respondents’ expectations (underlying
construct) in relation to the probability of endorsing an
item and is presented graphically for two items with the
highest discrimination from each domain.
Discussion
MAPLe-RA is a new questionnaire that was not yet val-
idated and its items were not examined. In this study,
we used factor analysis to assess the uni-dimentionality
and IRT to describe the properties of the items. The
study has shown that RA patients have high expecta-
tions from their treatment. These are particularly high
in the physical and psycho-social domains rather than
in the impact of new treatment domain. For the latter,
most items were unlikely to be endorsed by patients
Fig. 1 Two Parameter Logistic Model (2PLM) item characteristics ccurves (ICC), for two items from each domain of the MAPLe-RA scale
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with less than average expectations in this RA study
cohort.
Strength and limitations of the study
All domains have shown items with strong association
with the underlying construct (expectation), two to three
items from each domain, may be considered as good
candidates that differentiate between patients’ responses.
Several items however, appeared to be redundant (e.g.
visible signs of RA; not to have to change medication),
as they did not show strong association with the under-
lying construct.
The IRT method is superior to the traditionally fac-
tor extraction methods based on Eigenvalues [10, 11].
It is also a suitable way to employ when an instrument
includes response categories that have several levels. In
this study, the method determines whether the
categories perform as they were envisioned and/or
whether to collapse the responses into fewer categories
[17]. The advantage of using IRT is that of an under-
lying construct, that gives items different weights, de-
pending on the response pattern and the frequency of
response to each item, and values instead of sum
scores [12, 18]. This technique has been successfully
applied in the development or the evaluation of new
measures in patient-reported outcomes [19, 20]. To
our knowledge the IRT method has not been applied
in many Rheumatology related scale studies [21].
While the results of the new instrument appeared to
have a very good reliability, it is important to interpret
the findings with caution. This analysis was an explora-
tory phase of the scale development stages. The sample
size was under powered for IRT 2PL model and the
population studied was homogeneous from one RA
clinic only. Although, there were some redundant
items, we chose to keep these in the analysis to avoid
making inappropriate decisions and or conclusions at
this early stage.
Other studies have found similar results in that new
measure of patient’ expectations in general need valid-
ation in larger multi-centre studies [22]. We acknow-
ledge that further analysis is necessary, thus MAPLe-
RA is currently included in a national longitudinal ob-
servational study of patients with early Rheumatoid
Arthritis with a diversity of socio-demographic charac-
teristics and a long term follow up of 18 months, to be
completed in 2015. This large multi-centre study will
allow us to conduct a confirmatory analysis of the new
measure as well as to assess if patients expectations
change over time.
Conclusions
This study extends the evidence on the value of IRT
models in the assessment of health outcomes and
patient-generated measures. The result highlights that
RA patients’ treatment expectations are higher in the
physical and psycho-social domains and less so in the
impact of new treatment domain. RA patients expect
high degree of involvement in their care from health
care providers, and that they rate highly, controlling
their pain and emotional well-being.
Additional file
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(DOCX 17 kb)
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